Literature DB >> 4594755

[Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].

L Germain, J Frexinos, A Louis, A Ribet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4594755

Source DB:  PubMed          Journal:  Arch Fr Mal App Dig        ISSN： 0003-9772


× No keyword cloud information.
  4 in total

Review 1.  Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.

Authors:  Bodil Als-Nielsen; Lise L Gluud; Christian Gluud
Journal:  BMJ       Date:  2004-03-30

Review 2.  Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?

Authors:  Lise Lotte Gluud; Gitte Dam; Mette Borre; Iñigo Les; Juan Cordoba; Giulio Marchesini; Niels Kristian Aagaard; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2012-12-29       Impact factor: 3.584

Review 3.  Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.

Authors:  Lise Lotte Gluud; Hendrik Vilstrup; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2016-05-06

4.  Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.

Authors:  C E Atterbury; W C Maddrey; H O Conn
Journal:  Am J Dig Dis       Date:  1978-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.